Level 3 plus
I am a CE-certified medical device
I am safely connected
I have proven my social-economic evidence and get reimbursed by NIHDI
I am safely connected
I have proven my social-economic evidence and get reimbursed by NIHDI
Downloads
Languages
EN
FR
NL
General description
Additional info
Media
Financing
General description (provided by company)
Main purpose
Resilience is a solution dedicated to remote monitoring and support for oncology patients.
The Resilience mobile application accompanies people affected by cancer on a daily basis in order to help them cope with the side effects caused by their treatments and improve their quality of life.
The remote monitoring platform proposed by Resilience, a class IIa medical device, enables healthcare professionals to better understand and follow their patients remotely in order to improve their care.
The Resilience mobile application accompanies people affected by cancer on a daily basis in order to help them cope with the side effects caused by their treatments and improve their quality of life.
The remote monitoring platform proposed by Resilience, a class IIa medical device, enables healthcare professionals to better understand and follow their patients remotely in order to improve their care.
Target audience
Resilience improves patient follow-up in oncology care.
Resilience's remote monitoring platform is a class IIa medical device that allows healthcare professionals to better understand and follow their patients remotely in order to improve their care. Resilience is available in French, Dutch and English and is intended for all people affected by cancer or in remission.
Resilience's remote monitoring platform is a class IIa medical device that allows healthcare professionals to better understand and follow their patients remotely in order to improve their care. Resilience is available in French, Dutch and English and is intended for all people affected by cancer or in remission.
Approach
Resilience is developing a digital solution dedicated to the remote monitoring and support of people affected by cancer, as well as those who care for them. The company has major objectives to pursue its mission:
- To have a clinical impact on patients. Improving the quality of life of patients and their overall survival is Resilience's main objective. We want to enable them to live better and longer thanks to a more adapted, human and personalized support.
- Making the health care system more efficient. To universalize medical excellence in oncology so that every patient can benefit from it is Resilience's raison d'être, which is enshrined in its statutes as a company with a mission. We want to optimize care and make care paths more fluid. A more efficient healthcare system means more patients treated and better care provided.
The development of the Resilience telemonitoring platform is based on scientific studies that have proven the effectiveness of telemonitoring in oncology. Its clinical and organizational impacts, particularly on patients' overall survival and quality of life, have been demonstrated.
- To have a clinical impact on patients. Improving the quality of life of patients and their overall survival is Resilience's main objective. We want to enable them to live better and longer thanks to a more adapted, human and personalized support.
- Making the health care system more efficient. To universalize medical excellence in oncology so that every patient can benefit from it is Resilience's raison d'être, which is enshrined in its statutes as a company with a mission. We want to optimize care and make care paths more fluid. A more efficient healthcare system means more patients treated and better care provided.
The development of the Resilience telemonitoring platform is based on scientific studies that have proven the effectiveness of telemonitoring in oncology. Its clinical and organizational impacts, particularly on patients' overall survival and quality of life, have been demonstrated.
Connectivity to sensors and platforms
Connectivity to hospital information systems.
Financing and pricing model
Upon prescription by the oncologist
Adoption abroad
In France, Resilience PRO is marketed since 2021, and it is listed under article L.165-52 of the Social Security Code (CSS) thus being a health technology reimbursed under the French health system since October 2023.
Pathology
Cancer
Functions
Alerts & Notifications
Health Tracking
Personal Health Record
Remote Clinical Monitoring
Treatment Support
Users
Everyone
Additional info
Compliance to M3 criteria
This application has completed levels M1 and M2 of the pyramid, and the company declares to meet the criteria for mobile medical applications that NIHDI has set within the following specific care process:
Compliance to M2 criteria
Reimbursement request
Submission date
24-05-2024
Evaluation date
01-10-2024
Evaluation result
Self declaration to 6 ICT criteria
Criterion 1: GDPR app category
Criterion 2: Identification of the user in need of care
Criterion 3: App user authentication
Criterion 4: Verification of therapeutic relationship and informed consent
Criterion 5: Applied interoperability standards
Criterion 6: GDPR compliance
Extra: Secured Messaging
Compliance to M1 criteria
CE certification
Certificate granted on 22/02/2024
Certificate valid till 16/11/2028
Class type of medical device (More info): 2A
ISO Standards:
FAMHP registration and notification
Company registration number at FAMHP: 73718
Product identification code at FAMHP: 918021
General Data Protection Regulation (More info)
The app is only available through prescription
User instructions
Convinced that a better informed, understood and monitored patient is a better cared patient, Resilience offers a digital solution dedicated to remote monitoring and support of patients in oncology through two synergistic products.
A remote monitoring platform for healthcare professionals.
- The remote monitoring platform proposed by Resilience is a class IIa medical device that allows healthcare professionals to better understand and follow their patients remotely in order to improve their care.
- Real-time data collection, via an e-PRO (Patient Reported Outcomes) system, and an alert system allow the care team to detect and predict relapses, toxicities or complications encountered by patients, to proactively adapt management and to improve coordination of the care pathway.
- The development of the Resilience telemonitoring platform is based on reference scientific studies that have proven the effectiveness of telemonitoring in oncology. Its clinical and organizational impacts, notably on patients' overall survival and quality of life, have been demonstrated.
- Resilience's medical device can be indicated for all cancers, all phases and all treatments.
The mobile application for people affected by cancer
- The mobile application accompanies people affected by cancer to help them better cope with the side effects caused by their treatments and improve their quality of life.
- Patients can measure and track their symptoms, then through a personalized library of articles, videos and podcasts, each person can find concrete answers to their concerns and better understand them. The application also offers digital support programs (meditation, yoga, CBT, discussion groups, etc.) to help alleviate side effects and improve daily life. Thanks to these keys to understanding and calming down, patients can become actors in their own care.
- Co-constructed with the Gustave Roussy Institute (Europe's leading cancer center and the world's third largest cancer hospital), the Resilience application is a safe place to find the right information. It provides patients with reliable information, developed and validated by a team of multidisciplinary physicians.
- The application is intended for all people affected by cancer or in remission.
A remote monitoring platform for healthcare professionals.
- The remote monitoring platform proposed by Resilience is a class IIa medical device that allows healthcare professionals to better understand and follow their patients remotely in order to improve their care.
- Real-time data collection, via an e-PRO (Patient Reported Outcomes) system, and an alert system allow the care team to detect and predict relapses, toxicities or complications encountered by patients, to proactively adapt management and to improve coordination of the care pathway.
- The development of the Resilience telemonitoring platform is based on reference scientific studies that have proven the effectiveness of telemonitoring in oncology. Its clinical and organizational impacts, notably on patients' overall survival and quality of life, have been demonstrated.
- Resilience's medical device can be indicated for all cancers, all phases and all treatments.
The mobile application for people affected by cancer
- The mobile application accompanies people affected by cancer to help them better cope with the side effects caused by their treatments and improve their quality of life.
- Patients can measure and track their symptoms, then through a personalized library of articles, videos and podcasts, each person can find concrete answers to their concerns and better understand them. The application also offers digital support programs (meditation, yoga, CBT, discussion groups, etc.) to help alleviate side effects and improve daily life. Thanks to these keys to understanding and calming down, patients can become actors in their own care.
- Co-constructed with the Gustave Roussy Institute (Europe's leading cancer center and the world's third largest cancer hospital), the Resilience application is a safe place to find the right information. It provides patients with reliable information, developed and validated by a team of multidisciplinary physicians.
- The application is intended for all people affected by cancer or in remission.
Components of the application
Native appWeb applicationMedical device
Complaints handling
Via e-mail: paul-louis.belletante@resilience.careVia telephone: +33659671020
Media
